These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 17389734

  • 1. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T.
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [Abstract] [Full Text] [Related]

  • 2. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
    Surendran K, Schiavi S, Hruska KA.
    J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
    Vieira JM, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, Fujihara CK, Zatz R.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
    [Abstract] [Full Text] [Related]

  • 4. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
    Jung KJ, Kim J, Park YK, Yoon YR, Park KM.
    Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
    [Abstract] [Full Text] [Related]

  • 5. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
    Yang J, Liu Y.
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
    Tasanarong A, Kongkham S, Duangchana S, Thitiarchakul S, Eiam-Ong S.
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
    Abraham AP, Ma FY, Mulley WR, Ozols E, Nikolic-Paterson DJ.
    Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
    [Abstract] [Full Text] [Related]

  • 12. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY, Flanc RS, Tesch GH, Han Y, Atkins RC, Bennett BL, Friedman GC, Fan JH, Nikolic-Paterson DJ.
    J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
    [Abstract] [Full Text] [Related]

  • 13. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis.
    Jones LK, O'Sullivan KM, Semple T, Kuligowski MP, Fukami K, Ma FY, Nikolic-Paterson DJ, Holdsworth SR, Kitching AR.
    Nephrol Dial Transplant; 2009 Oct; 24(10):3024-32. PubMed ID: 19465557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy.
    Nishida M, Okumura Y, Sato H, Hamaoka K.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2520-4. PubMed ID: 18515792
    [Abstract] [Full Text] [Related]

  • 17. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA.
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [Abstract] [Full Text] [Related]

  • 18. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
    Zhang G, Kernan KA, Collins SJ, Cai X, López-Guisa JM, Degen JL, Shvil Y, Eddy AA.
    J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML, Weber M, Schulze-Lohoff E, Beirowski B, Segerer S, Gross O.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.